The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Artemisinin-Resistant Plasmodium falciparum Malaria
Open accessAbstract
For more than five decades, Southeast Asia (SEA) has been fertile ground for the emergence of drug-resistant Plasmodium falciparum malaria. After generating parasites resistant to chloroquine, sulfadoxine, pyrimethamine, quinine, and mefloquine, this region has now spawned parasites resistant to artemisinins, the world’s most potent antimalarial drugs. In areas where artemisinin resistance is prevalent, artemisinin combination therapies (ACTs)—the first-line treatments for malaria—are failing fast. This worrisome development threatens to make malaria practically untreatable in SEA, and threatens to compromise global endeavors to eliminate this disease. A recent series of clinical, in vitro , genomics, and transcriptomics studies in SEA have defined in vivo and in vitro phenotypes of artemisinin resistance, identified its causal genetic determinant, explored its molecular mechanism, and assessed its clinical impact. Specifically, these studies have established that artemisinin resistance manifests as slow parasite clearance in patients and increased survival of early-ring-stage parasites in vitro ; is caused by single nucleotide polymorphisms in the parasite’s K13 gene, is associated with an upregulated “unfolded protein response” pathway that may antagonize the pro-oxidant activity of artemisinins, and selects for partner drug resistance that rapidly leads to ACT failures. In SEA, clinical studies are urgently needed to monitor ACT efficacy where K13 mutations are prevalent, test whether new combinations of currently available drugs cure ACT failures, and advance new antimalarial compounds through preclinical pipelines and into clinical trials. Intensifying these efforts should help to forestall the spread of artemisinin and partner drug resistance from SEA to sub-Saharan Africa, where the world’s malaria transmission, morbidity, and mortality rates are highest.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
Self-citationSpread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S., Sreng, S., Anderson, J. M., Mao, S., Sam, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314981 · Cited by 2,205
Self-citationA molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Ariey, F., Witkowski, B., Amaratunga, C., Beghain, J., Langlois, A.-C., Khim, N., Kim, S., Duru, V., Bouchier, C., Ma, L., et al. (2014) · Nature · doi:10.1038/nature12876 · Cited by 2,090
Self-citationThe Role of Hemocytes in Anopheles gambiae Antiplasmodial Immunity
Ramirez, J. L., Garver, L. S., Brayner, F. A., Alves, L. C., Rodrigues, J., Molina-Cruz, A., & Barillas-Mury, C. (2014) · Journal of Innate Immunity · doi:10.1159/000353765 · Cited by 1,084
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67176-0 · Cited by 1,050
Dondorp, A. M., Fanello, C. I., Hendriksen, I. C., Gomes, E., Seni, A., Chhaganlal, K. D., Bojang, K., Olaosebikan, R., Anunobi, N., Maitland, K., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61924-1 · Cited by 1,022
Self-citationEmergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
Phyo, A. P., Nkhoma, S., Stepniewska, K., Ashley, E. A., Nair, S., McGready, R., ler Moo, C., Al-Saai, S., Dondorp, A. M., Lwin, K. M., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60484-x · Cited by 924
Self-citationMefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number
Price, R. N., Uhlemann, A.-C., Brockman, A., McGready, R., Ashley, E., Phaipun, L., Patel, R., Laing, K., Looareesuwan, S., White, N. J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16767-6 · Cited by 853
K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates
Straimer, J., Gnädig, N. F., Witkowski, B., Amaratunga, C., Duru, V., Ramadani, A. P., Dacheux, M., Khim, N., Zhang, L., Lam, S., et al. (2015) · Science · doi:10.1126/science.1260867 · Cited by 728
Self-citationGenome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system
Ghorbal, M., Gorman, M., Macpherson, C. R., Martins, R. M., Scherf, A., & Lopez-Rubio, J.-J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2925 · Cited by 653
Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum
Wang, J., Zhang, C.-J., Chia, W. N., Loh, C. C. Y., Li, Z., Lee, Y. M., He, Y., Yuan, L.-X., Lim, T. K., Liu, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms10111 · Cited by 633
Witkowski, B., Amaratunga, C., Khim, N., Sreng, S., Chim, P., Kim, S., Lim, P., Mao, S., Sopha, C., Sam, B., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70252-4 · Cited by 629
Self-citationGenetic architecture of artemisinin-resistant Plasmodium falciparum
Miotto, O., Amato, R., Ashley, E. A., MacInnis, B., Almagro-Garcia, J., Amaratunga, C., Lim, P., Mead, D., Oyola, S. O., Dhorda, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3189 · Cited by 609
Self-citationA molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria
Mbengue, A., Bhattacharjee, S., Pandharkar, T., Liu, H., Estiu, G., Stahelin, R. V., Rizk, S. S., Njimoh, D. L., Ryan, Y., Chotivanich, K., et al. (2015) · Nature · doi:10.1038/nature14412 · Cited by 597
Self-citationAmaratunga, C., Lim, P., Suon, S., Sreng, S., Mao, S., Sopha, C., Sam, B., Dek, D., Try, V., Amato, R., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00487-9 · Cited by 493
Self-citationMultiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia
Miotto, O., Almagro-Garcia, J., Manske, M., MacInnis, B., Campino, S., Rockett, K. A., Amaratunga, C., Lim, P., Suon, S., Sreng, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2624 · Cited by 462
Self-citationMok, S., Ashley, E. A., Ferreira, P. E., Zhu, L., Lin, Z., Yeo, T., Chotivanich, K., Imwong, M., Pukrittayakamee, S., Dhorda, M., et al. (2015) · Science · doi:10.1126/science.1260403 · Cited by 435
Self-citationTakala-Harrison, S., Jacob, C. G., Arze, C., Cummings, M. P., Silva, J. C., Dondorp, A. M., Fukuda, M. M., Hien, T. T., Mayxay, M., Noedl, H., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu491 · Cited by 422
Self-citationTun, K. M., Imwong, M., Lwin, K. M., Win, A. A., Hlaing, T. M., Hlaing, T., Lin, K., Kyaw, M. P., Plewes, K., Faiz, M. A., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70032-0 · Cited by 414
Self-citationA Major Genome Region Underlying Artemisinin Resistance in Malaria
Cheeseman, I. H., Miller, B. A., Nair, S., Nkhoma, S., Tan, A., Tan, J. C., Al Saai, S., Phyo, A. P., Moo, C. L., Lwin, K. M., et al. (2012) · Science · doi:10.1126/science.1215966 · Cited by 381
Self-citationAmaratunga, C., Sreng, S., Suon, S., Phelps, E. S., Stepniewska, K., Lim, P., Zhou, C., Mao, S., Anderson, J. M., Lindegardh, N., et al. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70181-0 · Cited by 344
Self-citationTargeting the Cell Stress Response of Plasmodium falciparum to Overcome Artemisinin Resistance
Dogovski, C., Xie, S. C., Burgio, G., Bridgford, J., Mok, S., McCaw, J. M., Chotivanich, K., Kenny, S., Gnädig, N., Straimer, J., et al. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002132 · Cited by 327
Self-citationDeclining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand Border
Wongsrichanalai, C., & Meshnick, S. R. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1405.071601 · Cited by 309
Reduced Artemisinin Susceptibility of Plasmodium falciparum Ring Stages in Western Cambodia
Witkowski, B., Khim, N., Chim, P., Kim, S., Ke, S., Kloeung, N., Chy, S., Duong, S., Leang, R., Ringwald, P., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01868-12 · Cited by 308
Self-citationLeang, R., Taylor, W. R. J., Bouth, D. M., Song, L., Tarning, J., Char, M. C., Kim, S., Witkowski, B., Duru, V., Domergue, A., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00835-15 · Cited by 302
Genomic epidemiology of artemisinin resistant malaria
MalariaGEN Plasmodium falciparum Community Project (2016) · eLife · doi:10.7554/elife.08714 · Cited by 297
Venkatesan, M., Gadalla, N. B., Stepniewska, K., Dahal, P., Nsanzabana, C., Moriera, C., Price, R. N., Mårtensson, A., Rosenthal, P. J., Dorsey, G., et al. (2014) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0031 · Cited by 285
Flegg, J. A., Guerin, P. J., White, N. J., & Stepniewska, K. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-339 · Cited by 285
Taylor, S. M., Parobek, C. M., DeConti, D. K., Kayentao, K., Coulibaly, S. O., Greenwood, B. M., Tagbor, H., Williams, J., Bojang, K., Njie, F., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu467 · Cited by 283
The Threat of Artemisinin-Resistant Malaria
Dondorp, A. M., Fairhurst, R. M., Slutsker, L., MacArthur, J. R., M.D., J. G. B., Guerin, P. J., Wellems, T. E., Ringwald, P., Newman, R. D., & Plowe, C. V. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1108322 · Cited by 273
Self-citationTakala-Harrison, S., Clark, T. G., Jacob, C. G., Cummings, M. P., Miotto, O., Dondorp, A. M., Fukuda, M. M., Nosten, F., Noedl, H., Imwong, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211205110 · Cited by 266
Self-citationK13-Propeller Polymorphisms in Plasmodium falciparum Parasites From Sub-Saharan Africa
Kamau, E., Campino, S., Amenga-Etego, L., Drury, E., Ishengoma, D., Johnson, K., Mumba, D., Kekre, M., Yavo, W., Mead, D., et al. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu608 · Cited by 258
Spring, M. D., Lin, J. T., Manning, J. E., Vanachayangkul, P., Somethy, S., Bun, R., Se, Y., Chann, S., Ittiverakul, M., Sia-ngam, P., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70049-6 · Cited by 244
Spiroindolone KAE609 for Falciparum and Vivax Malaria
White, N. J., Pukrittayakamee, S., Phyo, A. P., Rueangweerayut, R., Nosten, F., Jittamala, P., Jeeyapant, A., Jain, J. P., Lefèvre, G., Li, R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315860 · Cited by 240
Reduced Susceptibility of Plasmodium falciparum to Artesunate in Southern Myanmar
Kyaw, M. P., Nyunt, M. H., Chit, K., Aye, M. M., Aye, K. H., Aye, M. M., Lindegardh, N., Tarning, J., Imwong, M., Jacob, C. G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057689 · Cited by 199
White, N. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-278 · Cited by 199
Duru, V., Khim, N., Leang, R., Kim, S., Domergue, A., Kloeung, N., Ke, S., Chy, S., Eam, R., Khean, C., et al. (2015) · BMC Medicine · doi:10.1186/s12916-015-0539-5 · Cited by 197
Phyo, A. P., Jittamala, P., Nosten, F. H., Pukrittayakamee, S., Imwong, M., White, N. J., Duparc, S., Macintyre, F., Baker, M., & Möhrle, J. J. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00320-5 · Cited by 185
Leang, R., Barrette, A., Bouth, D. M., Menard, D., Abdur, R., Duong, S., & Ringwald, P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00686-12 · Cited by 185
Okell, L. C., Drakeley, C. J., Ghani, A. C., Bousema, T., & Sutherland, C. J. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-125 · Cited by 162
Primaquine to prevent transmission of falciparum malaria
White, N. J. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70198-6 · Cited by 158
Pukrittayakamee, S., Chotivanich, K., Chantra, A., Clemens, R. L., Looareesuwan, S., & White, N. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1329-1334.2004 · Cited by 156
Huang, F. J., Takala‐Harrison, S., Jacob, C. G., Liu, H., Sun, X., Yang, H., Nyunt, M. M., Adams, M., Zhou, S., Xia, Z., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv249 · Cited by 149
Ex vivo perfusion of human spleens maintains clearing and processing functions
Buffet, P. A., Milon, G., Brousse, V. A. M., Corréas, J.-M., Dousset, B. E., Couvelard, A., Kianmanesh, R., Farges, O., Sauvanet, A., Paye, F., et al. (2005) · Blood · doi:10.1182/blood-2005-10-4094 · Cited by 146
In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam
Hien, T. T., Nguyen, T.-N., Phu, N. H., Boni, M. F., Thanh, N. V., Nha-Ca, N. T., Thai, L. H., Thai, C. Q., Toi, P. V., Thuan, P. D., et al. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-355 · Cited by 144
Chenet, S. M., Okoth, S. A., Huber, C. S., Chandrabose, J., Lucchi, N. W., Talundzic, E., Krishnalall, K., Ceron, N., Musset, L., de Oliveira, A. M., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv752 · Cited by 139
Hott, A., Casandra, D. R., Sparks, K. N., Morton, L. C., Castanares, G.-G., Rutter, A., & Kyle, D. E. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00197-15 · Cited by 131
Conrad, M. D., Bigira, V., Kapisi, J., Muhindo, M. K., Kamya, M. R., Havlir, D. V., Dorsey, G., & Rosenthal, P. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105690 · Cited by 130
The Mechanisms of Parasite Clearance after Antimalarial Treatment ofPlasmodium falciparumMalaria
Chotivanich, K., Udomsangpetch, R., Dondorp, A. M., Williams, T., Angus, B., Simpson, J. A., Pukrittayakamee, S., Looareesuwan, S., Newbold, C., & White, N. J. (2000) · The Journal of Infectious Diseases · doi:10.1086/315718 · Cited by 122
Self-citationTalundzic, E., Okoth, S. A., Congpuong, K., Pluciński, M. M., Morton, L. C., Goldman, I. F., Kachur, S. P., Wongsrichanalai, C., Satimai, W., Barnwell, J. W., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004789 · Cited by 119
Mutations in Plasmodium falciparum K13 propeller gene from Bangladesh (2009–2013)
Mohon, A. N., Alam, M. S., Bayih, A. G., Folefoc, A., Shahinas, D., Haque, R., & Pillai, D. R. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-431 · Cited by 107
Thriemer, K., Hong, N. V., Rosanas‐Urgell, A., Phuc, B. Q., Ha, D. M., Pockele, E., Guetens, P., Van, N. V., Duong, T. T., Amambua‐Ngwa, A., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02746-14 · Cited by 106
Leong, F. J., Li, R., Jain, J. P., Lefèvre, G. Y., Magnusson, B., Diagana, T. T., & Pertel, P. E. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03393-14 · Cited by 105
Ouattara, A., Koné, A., Adams, M., Fofana, B., Maiga, A. W., Hampton, S., Coulibaly, D., Thera, M. A., Diallo, N., Dara, A., et al. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0605 · Cited by 105
Understanding artemisinin-resistant malaria
Fairhurst, R. M. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000199 · Cited by 100
Self-citationWang, Z., Shrestha, S., Li, X., Miao, J., Yuan, L., Cabrera, M., Grube, C., Yang, Z., & Cui, L. (2015) · Malaria Journal · doi:10.1186/s12936-015-0672-9 · Cited by 96
A Unique Plasmodium falciparum K13 Gene Mutation in Northwest Ethiopia
Bayih, A. G., Getnet, G., Alemu, A., Getie, S., Mohon, A. N., & Pillai, D. R. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.15-0477 · Cited by 89
Wang, Z., Wang, Y., Cabrera, M., Zhang, Y., Gupta, B., Wu, Y., Kemirembe, K., Hu, Y., Liang, X., Brashear, A., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01255-15 · Cited by 87
Mishra, N., Prajapati, S. K., Kaitholia, K., Bharti, R. S., Srivastava, B., Phookan, S., Anvikar, A. R., Dev, V., Sonal, G. S., Dhariwal, A. C., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04632-14 · Cited by 87
Effect of red blood cell variants on childhood malaria in Mali: a prospective cohort study
Lopera-Mesa, T. M., Doumbia, S., Konate, D. S., Anderson, J. M., Doumbouya, M., Keita, A. S., Diakité, S. A. S., Traoré, K., Krause, M., Diouf, A., et al. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00043-5 · Cited by 81
Self-citationNyunt, M. H., Hlaing, T., Oo, H. W., Tin-Oo, L.-L. K., Phway, H. P., Wang, B., Zaw, N. N., Han, S. S., Tun, T., San, K. K., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu1160 · Cited by 79
Chaorattanakawee, S., Saunders, D., Sea, D., Chanarat, N., Yingyuen, K., Sundrakes, S., Saingam, P., Buathong, N., Sriwichai, S., Chann, S., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00366-15 · Cited by 75
Lopera-Mesa, T. M., Doumbia, S., Chiang, S., Zeituni, A. E., Konate, D. S., Doumbouya, M., Keita, A. S., Stepniewska, K., Traoré, K., Diakité, S. A. S., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit082 · Cited by 74
Self-citationLeong, F. J., Zhao, R., Zeng, S., Magnusson, B., Diagana, T. T., & Pertel, P. E. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03478-14 · Cited by 71
Cooper, R. A., Conrad, M. D., Watson, Q. D., Huezo, S. J., Ninsiima, H., Tumwebaze, P. K., Nsobya, S. L., & Rosenthal, P. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00921-15 · Cited by 68
Boussaroque, A., Fall, B., Madamet, M., Camara, C., Benoît, N., Fall, M., Nakoulima, A. D., Dionne, P., Fall, K. B., Diatta, B., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01346-15 · Cited by 67
Laurent, B. S., Miller, B., Burton, T. A., Amaratunga, C., Men, S., Sovannaroth, S., Fay, M. P., Miotto, O., Gwadz, R. W., Anderson, J. M., et al. (2015) · Nature Communications · doi:10.1038/ncomms9614 · Cited by 67
Self-citationNdour, P. A., Lopera-Mesa, T. M., Diakité, S. A. S., Chiang, S., Mouri, O., Roussel, C., Jauréguiberry, S., Biligui, S., Kendjo, É., Claessens, A., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu427 · Cited by 64
Self-citationSlow Clearance ofPlasmodium falciparumin Severe Pediatric Malaria, Uganda, 2011–2013
Hawkes, M., Conroy, A. L., Opoka, R. O., Namasopo, S., Zhong, K., Liles, W. C., John, C. C., & Kain, K. C. (2015) · Emerging infectious diseases · doi:10.3201/eid2107.150213 · Cited by 63
An outbreak of artemisinin resistant falciparum malaria in Eastern Thailand
Imwong, M., Jindakhad, T., Kunasol, C., Sutawong, K., Vejakama, P., & Dondorp, A. M. (2015) · Scientific Reports · doi:10.1038/srep17412 · Cited by 58
Self-citationBosman, P., Stassijns, J., Nackers, F., Canier, L., Kim, N., Khim, S., Alipon, S. C., Char, M. C., Nguon, C., Lek, D., et al. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-394 · Cited by 51
Amaratunga, C., Witkowski, B., Dek, D., Try, V., Khim, N., Miotto, O., Ménard, D., & Fairhurst, R. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03055-14 · Cited by 48
Self-citationDefining the In Vivo Phenotype of Artemisinin-Resistant Falciparum Malaria: A Modelling Approach
White, L. J., Flegg, J. A., Phyo, A. P., Wiladpai-ngern, J. H., Bethell, D., Plowe, C. V., Anderson, T., Nkhoma, S. C., Nair, S., Tripura, R., et al. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001823 · Cited by 43
Self-citationFeng, J., Zhou, D.-L., Lin, Y.-X., Xiao, H., Yan, H., & Xia, Z. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04843-14 · Cited by 42
Putaporntip, C., Kuamsab, N., Kosuwin, R., Tantiwattanasub, W., Vejakama, P., Sueblinvong, T., Seethamchai, S., Jongwutiwes, S., & Hughes, A. L. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.10.027 · Cited by 36
Huang, B., Deng, C., Yang, T., Xue, L., Wang, Q., Huang, S., Su, X., Liu, Y., Zheng, S., Guan, Y., et al. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-1253-z · Cited by 36
Lim, P., Dek, D., Try, V., Sreng, S., Suon, S., & Fairhurst, R. M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05163-14 · Cited by 34
Self-citationMadamet, M., Collet, L., Lepère, J., Benoît, N., Amalvict, R., Ménard, D., & Pradines, B. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01251-15 · Cited by 32
Maïga‐Ascofaré, O., & May, J. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv414 · Cited by 28
Cited by
Haldar, K., Bhattacharjee, S., & Safeukui, I. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.161 · Cited by 431
Quan, J., Langelier, C., Kuchta, A., Batson, J., Teyssier, N., Lyden, A., Caldera, S., McGeever, A., Dimitrov, B., King, R., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz418 · Cited by 261
Antimalarial drug resistance in Africa: the calm before the storm?
Conrad, M. D., & Rosenthal, P. J. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30261-0 · Cited by 255
Metadata
- Authors
- Fairhurst, R. M., & Dondorp, A. M.
- Venue
- Microbiology Spectrum
- Publisher
- American Society for Microbiology
- Published
- 2016-05-06
- Volume
- 4
- Issue
- 3
- ISSN
- 2165-0497 (ISSN-L)
- OpenAlex
- W2467614481
- Cited by
- 303
- References
- 79
- FWCI
- 28.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.